(Q44647876)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14606641%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Treatment of desmoids and mesenteric fibromatosis in familial adenomatous polyposis with raloxifene (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14606641%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Treatment of Desmoids and Mesenteric Fibromatosis in Familial Adenomatous Polyposis with Raloxifene (English)

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

familial adenomatous polyposis

30 March 2024

main subject

1 reference

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

30 March 2024

4

Maria Luisa Brandi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14606641%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Francesco Tonelli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14606641%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Ferdinando Ficari

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14606641%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Rosa Valanzano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14606641%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14606641

30 March 2024

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14606641%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

20 December 2019

http://journals.sagepub.com/doi/pdf/10.1177/030089160308900408

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

30 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14606641%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14606641%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14606641%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

391-396

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14606641%20AND%20SRC:MED&resulttype=core&format=json

Mesenteric fibromatosis complicating familial adenomatous polyposis: predisposing factors and results of treatment

20 December 2019

cites work

3

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Desmoid tumours in familial adenomatous polyposis

30 March 2024

4

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Novel mutations and inactivation of both alleles of the APC gene in desmoid tumors

30 March 2024

7

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Causes of death in patients with familial polyposis coli (FPC).

30 March 2024

8

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

The value of screening and central registration of families with familial adenomatous polyposis. A study of 82 families in The Netherlands.

30 March 2024

9

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Causes of death and postsurgical survival in familial adenomatous polyposis: results from the Italian Registry. Italian Registry of Familial Polyposis Writing Committee.

30 March 2024

10

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment

30 March 2024

11

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Desmoid tumors: a novel approach for local control

30 March 2024

12

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

External beam radiotherapy for primary and adjuvant management of aggressive fibromatosis

30 March 2024

13

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Combination chemotherapy for desmoid tumors

30 March 2024

14

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment

30 March 2024

15

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Desmoid tumours complicating familial adenomatous polyposis

30 March 2024

16

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Desmoids in familial adenomatous polyposis

30 March 2024

17

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis

30 March 2024

18

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Testolactone, sulindac, warfarin, and vitamin K1 for unresectable desmoid tumors

30 March 2024

19

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

The use of indomethacin, sulindac, and tamoxifen for the treatment of desmoid tumors associated with familial polyposis

30 March 2024

20

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Successful treatment of a desmoid tumor with doxorubicin

30 March 2024

21

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Recent trends in the management of desmoid tumors. Summary of 19 cases and review of the literature

30 March 2024

24

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Treatment of Intra-abdominal and Abdominal Wall Desmoid Tumors With Drugs That Affect the Metabolism of Cyclic 3', 5'-Adenosine Monophosphate

30 March 2024

25

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Combination chemotherapy in adult desmoid tumors

30 March 2024

26

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Apoptosis induced by sulindac sulfide in epithelial and mesenchymal cells from human abdominal neoplasms

30 March 2024

27

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Desmoid tumors and their management

30 March 2024

28

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Remission of rapidly growing desmoid tumors after tamoxifen therapy

30 March 2024

29

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

A recurrent pelvic desmoid tumor successfully treated with tamoxifen

30 March 2024

30

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Response of multicentric desmoid tumours to tamoxifen

30 March 2024

31

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Endocrine therapy for desmoid tumors

30 March 2024

32

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Treatment of mesenteric desmoid tumours with the anti-oestrogenic agent toremifene: case histories and an overview of the literature.

30 March 2024

33

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Sequential treatment of recurrent mesenteric desmoid tumor

30 March 2024

34

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

30 March 2024

35

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

30 March 2024

36

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Molecular determinants of tissue selectivity in estrogen receptor modulators

30 March 2024

37

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients

30 March 2024

38

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial

30 March 2024

39

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

30 March 2024

40

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

30 March 2024

41

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Functional estrogen receptor beta in colon cancer cells

30 March 2024

43

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

30 March 2024

44

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Cognitive function in postmenopausal women treated with raloxifene

30 March 2024

45

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Estrogen and antiestrogen binding sites in desmoid tumors

30 March 2024

46

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Modification of growth of desmoid tumours in tissue culture by anti-oestrogenic substances: a preliminary report.

30 March 2024

48

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats

30 March 2024

49

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Desmoid tumours treated with triphenylethylenes

30 March 2024

51

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

30 March 2024

52

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis

30 March 2024

54

1 reference

https://api.crossref.org/works/10.1177/030089160308900408

30 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14606641%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference